NC-MG-FOODS
10.3.2021 22:10:07 CET | Business Wire | Press release
MG Foods of Charlotte, NC is recalling various Turkey Sandwiches due to a potential contamination of Listeria monocytogenes . Listeria monocytogenes is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, a Listeria monocytogenes infection can cause miscarriages and stillbirths among pregnant women.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210310005930/en/
The products were distributed between March 3, 2021 and March 5, 2021 and packaged in clear plastic wedges & paper bags. The products were sold at distributors located at the Charlotte Douglas Airport and via vending machines and micro markets located in business locations in Georgia, North Carolina, South Carolina, and West Virginia. The company reacted swiftly and as of end-of-day March 5, 2021 affected products were removed from sale at all locations.
No illnesses have been reported to date.
On March 2, 2021 during routine environmental testing the company detected the presence of Listeria on surface areas where the recalled products were produced. Out of an abundance of caution, MG Foods is recalling the products due to the potential that some product may be contaminated with Listeria monocytogenes .
Products recalled at the Charlotte Douglas Airport are:
PRODUCT |
SIZE |
UPC |
CONTAINER |
USE BY DATES |
MG Foods Combo Half & Half |
6.82 oz |
1 00000 50069 9 |
Plastic Wedge |
3/9/2021 |
MG Foods Turkey & Cheddar BLT |
6.9 oz |
1 00000 50068 2 |
Plastic Wedge |
3/7/2021 |
MG Foods Turkey & Swiss Croissant |
7.5 oz |
1 00000 50011 8 |
Brown Bag |
3/7/2021 |
Products recalled in vending machines and micro markets located in Georgia, North Carolina, South Carolina and West Virginia are:
PRODUCT |
SIZE |
UPC |
CONTAINER |
USE BY DATES |
Fresh to You Club on Toast |
10.3 oz |
MGF0930 |
Plastic Wrap |
3/7/2021 |
Fresh to You Club Panini |
8.50 oz |
MGF9844 |
Plastic Wrap |
3/7/2021 |
Fresh to You Club Sub |
9.14 oz |
C0932 |
Plastic Wrap |
3/7/2021 |
Fresh to You Club Sub |
9.14 oz |
MGF9100 |
Plastic Wrap |
3/7/2021 |
Fresh to You Deluxe Triple Decker Club |
12.17 oz |
MGF9719 |
Plastic Wrap |
3/7/2021 |
Fresh to You Ham & Turkey Combo |
5.85 oz |
MGF3054 |
Plastic Wedge |
3/9/2021 |
Fresh to You Ham & Turkey Combo on 12 Grain |
7.20 oz |
MGF6011 |
Plastic Wedge |
3/9/2021 |
Fresh to You Jumbo Turkey & Cheese Sub |
6.74 oz |
MGF1002 |
Plastic Wrap |
3/9/2021 |
Fresh to You Market Club |
11.85 oz |
MGF9800 |
Plastic Wrap |
3/7/2021 |
Fresh to You Market Ham & Turkey Combo |
5.85 oz |
MGF23054 |
Plastic Wrap |
3/9/2021 |
Fresh to You Market Shaved Turkey & Cheese |
4.55 oz |
MGF25571 |
Plastic Wedge |
3/9/2021 |
Fresh to You Shaved Turkey & Cheese |
4.55 oz |
MGF5571 |
Plastic Wedge |
3/9/2021 |
Fresh to You Turkey & Baby Swiss on a Honey Brown Roll |
9.42 oz |
MGF9703 |
Plastic Wrap |
3/7/2021 |
Fresh to You Turkey & Cheddar Club |
10.02 oz |
MGF9710 |
Plastic Wedge |
3/7/2021 |
Fresh to You Turkey & Cheese Cut |
6.56 oz |
MGF0596 |
Plastic Wedge |
3/9/2021 |
Fresh to You Turkey & Cheese Hoagie |
6.35 oz |
MGF0597 |
Plastic Wrap |
3/9/2021 |
Fresh to You Turkey & Sun-Dried Tomato Aioli on Pita |
8.29 oz |
MGF9806 |
Plastic Wrap |
3/7/2021 |
Fresh to You Turkey & Swiss on a Kaiser Roll |
8.1 oz |
MGF9712 |
Plastic Wrap |
3/7/2021 |
Fresh to You Turkey & Swiss on a Wheat Roll |
5.22 oz |
MGF0854 |
Plastic Wrap |
3/9/2021 |
Fresh to You Turkey & Swiss on Whole Wheat |
3.9 oz |
MGF0283 |
Plastic Wedge |
3/9/2021 |
Fresh to You Turkey Club Croissant |
7.94 oz |
MGF9103 |
Plastic Square |
3/7/2021 |
Fresh to You Turkey Cranberry Pita |
9.0 oz |
MGF9804 |
Plastic Wrap |
3/7/2021 |
Fresh to You Turkey Melt Croissant |
6.7 oz |
MGF3032 |
Plastic Wrap |
3/9/2021 |
Fresh to You Tuscan Turkey Ciabatta |
9.18 oz |
MGF9810 |
Plastic Wrap |
3/7/2021 |
MG Foods Combo Half & Half |
6.82 oz |
1 00000 50069 9 |
Plastic Wedge |
3/9/2021 |
MG Foods The Club Sub |
8.5 oz |
1 00000 50002 6 |
Brown Bag |
3/9/2021 |
MG Foods Turkey & Cheddar BLT |
6.9 oz |
1 00000 50068 2 |
Plastic Wedge |
3/7/2021 |
MG Foods Turkey & Pepperjack Sub |
7.9 oz |
1 00000 50055 2 |
Brown Bag |
3/7/2021 |
MG Foods Turkey & Provolone BLT |
8.1 oz |
1 00000 50065 1 |
Plastic Wedge |
3/7/2021 |
MG Foods Turkey & Provolone on 12 Grain |
8.9 oz |
1 00000 50066 8 |
Plastic Wedge |
3/7/2021 |
MG Foods Turkey & Swiss Croissant |
7.5 oz |
1 00000 50011 8 |
Brown Bag |
3/7/2021 |
Product labels are attached for identification of products.
Consumers who have purchased these products are urged to discard any remaining product. Consumers may contact MG Foods at 1-855-424-8390 Monday thru Friday 7:00 am – 7:00 pm ET for any questions related to this recall or to request a full refund.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210310005930/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom